Patel Purav 4
4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Patel Purav
Director
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2022-11-18$4.69/sh+3,000$14,070→ 43,547 total
Holdings
- 28,742(indirect: By LLC)
Common Stock, par value $0.0001 per share
- 3,318(indirect: By LLC)
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.